APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Computer-Aided Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Computer-Aided Drug Market Analysis and Forecast 2026-2032

Report ID 173980540231 December 2025190 pages

Choose your research edition.

Industry ResearchComputer-Aided Drug Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Computer-Aided Drug Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Computer-Aided Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Computer-Aided Drug Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Computer-Aided Drug Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Computer-Aided Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Computer-Aided Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Computer-Aided Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Computer-Aided Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Computer-Aided Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Computer-Aided Drug include Aaranya Biosciences Pvt. Ltd., Albany Molecular Research Inc., Charles River Laboratories International Inc., Chembio Discovery Inc., Chemical Computing Group ULC, Compchem Solutions Ltd., International Business Machines Corp., Kang Yusheng Information Technology Co. Ltd. and Market Positioning Of Vendors, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Computer-Aided Drug, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Computer-Aided Drug, also provides the revenue of main regions and countries. Of the upcoming market potential for Computer-Aided Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Computer-Aided Drug revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Computer-Aided Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Computer-Aided Drug revenue, projected growth trends, production technology, application and end-user industry.

Computer-Aided Drug Segment by Company

Aaranya Biosciences Pvt. Ltd.

Albany Molecular Research Inc.

Charles River Laboratories International Inc.

Chembio Discovery Inc.

Chemical Computing Group ULC

Compchem Solutions Ltd.

International Business Machines Corp.

Kang Yusheng Information Technology Co. Ltd.

Market Positioning Of Vendors

Openeye Scientific Software Inc.

Pharmaron Beijing Co. Ltd.

Computer-Aided Drug Segment by Type

Structure Based Drug

Ligand Based Drug

Computer-Aided Drug Segment by Application

Oncological Disorders

Neurological Disorders

Other

Computer-Aided Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Computer-Aided Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Computer-Aided Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Computer-Aided Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Computer-Aided Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Computer-Aided Drug company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Computer-Aided Drug revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Computer-Aided Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Structure Based Drug Major Player Table 3. Ligand Based Drug Major Player Table 4. Global Computer-Aided Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Oncological Disorders Major Player Table 6. Neurological Disorders Major Player Table 7. Other Major Player Table 8. Computer-Aided Drug Industry Trends Table 9. Computer-Aided Drug Industry Drivers Table 10. Computer-Aided Drug Industry Opportunities and Challenges Table 11. Computer-Aided Drug Industry Restraints Table 12. Global Computer-Aided Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Computer-Aided Drug Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Computer-Aided Drug Market Share by Region (2021-2026) Table 15. Global Computer-Aided Drug Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Computer-Aided Drug Market Share by Region (2027-2032) Table 17. Global Computer-Aided Drug Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Computer-Aided Drug Revenue Market Share by Players (2021-2026) Table 19. Global Computer-Aided Drug Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Computer-Aided Drug Key Players Headquarters & Area Served Table 21. Global Computer-Aided Drug Players, Product Type & Application Table 22. Global Computer-Aided Drug Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Computer-Aided Drug by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Computer-Aided Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Computer-Aided Drug Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Computer-Aided Drug Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Computer-Aided Drug Revenue Market Share by Type (2021-2026) Table 29. Global Computer-Aided Drug Revenue Market Share by Type (2027-2032) Table 30. Global Computer-Aided Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Computer-Aided Drug Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Computer-Aided Drug Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Computer-Aided Drug Revenue Market Share by Application (2021-2026) Table 34. Global Computer-Aided Drug Revenue Market Share by Application (2027-2032) Table 35. Aaranya Biosciences Pvt. Ltd. Company Information Table 36. Aaranya Biosciences Pvt. Ltd. Business Overview Table 37. Aaranya Biosciences Pvt. Ltd. Computer-Aided Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Aaranya Biosciences Pvt. Ltd. Computer-Aided Drug Product Portfolio Table 39. Aaranya Biosciences Pvt. Ltd. Recent Development Table 40. Albany Molecular Research Inc. Company Information Table 41. Albany Molecular Research Inc. Business Overview Table 42. Albany Molecular Research Inc. Computer-Aided Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Albany Molecular Research Inc. Computer-Aided Drug Product Portfolio Table 44. Albany Molecular Research Inc. Recent Development Table 45. Charles River Laboratories International Inc. Company Information Table 46. Charles River Laboratories International Inc. Business Overview Table 47. Charles River Laboratories International Inc. Computer-Aided Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Charles River Laboratories International Inc. Computer-Aided Drug Product Portfolio Table 49. Charles River Laboratories International Inc. Recent Development Table 50. Chembio Discovery Inc. Company Information Table 51. Chembio Discovery Inc. Business Overview Table 52. Chembio Discovery Inc. Computer-Aided Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Chembio Discovery Inc. Computer-Aided Drug Product Portfolio Table 54. Chembio Discovery Inc. Recent Development Table 55. Chemical Computing Group ULC Company Information Table 56. Chemical Computing Group ULC Business Overview Table 57. Chemical Computing Group ULC Computer-Aided Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Chemical Computing Group ULC Computer-Aided Drug Product Portfolio Table 59. Chemical Computing Group ULC Recent Development Table 60. Compchem Solutions Ltd. Company Information Table 61. Compchem Solutions Ltd. Business Overview Table 62. Compchem Solutions Ltd. Computer-Aided Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Compchem Solutions Ltd. Computer-Aided Drug Product Portfolio Table 64. Compchem Solutions Ltd. Recent Development Table 65. International Business Machines Corp. Company Information Table 66. International Business Machines Corp. Business Overview Table 67. International Business Machines Corp. Computer-Aided Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. International Business Machines Corp. Computer-Aided Drug Product Portfolio Table 69. International Business Machines Corp. Recent Development Table 70. Kang Yusheng Information Technology Co. Ltd. Company Information Table 71. Kang Yusheng Information Technology Co. Ltd. Business Overview Table 72. Kang Yusheng Information Technology Co. Ltd. Computer-Aided Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Kang Yusheng Information Technology Co. Ltd. Computer-Aided Drug Product Portfolio Table 74. Kang Yusheng Information Technology Co. Ltd. Recent Development Table 75. Market Positioning Of Vendors Company Information Table 76. Market Positioning Of Vendors Business Overview Table 77. Market Positioning Of Vendors Computer-Aided Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Market Positioning Of Vendors Computer-Aided Drug Product Portfolio Table 79. Market Positioning Of Vendors Recent Development Table 80. Openeye Scientific Software Inc. Company Information Table 81. Openeye Scientific Software Inc. Business Overview Table 82. Openeye Scientific Software Inc. Computer-Aided Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Openeye Scientific Software Inc. Computer-Aided Drug Product Portfolio Table 84. Openeye Scientific Software Inc. Recent Development Table 85. Pharmaron Beijing Co. Ltd. Company Information Table 86. Pharmaron Beijing Co. Ltd. Business Overview Table 87. Pharmaron Beijing Co. Ltd. Computer-Aided Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Pharmaron Beijing Co. Ltd. Computer-Aided Drug Product Portfolio Table 89. Pharmaron Beijing Co. Ltd. Recent Development Table 90. North America Computer-Aided Drug Revenue by Type (2021-2026) & (US$ Million) Table 91. North America Computer-Aided Drug Revenue by Type (2027-2032) & (US$ Million) Table 92. North America Computer-Aided Drug Revenue by Application (2021-2026) & (US$ Million) Table 93. North America Computer-Aided Drug Revenue by Application (2027-2032) & (US$ Million) Table 94. North America Computer-Aided Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. North America Computer-Aided Drug Revenue by Country (2021-2026) & (US$ Million) Table 96. North America Computer-Aided Drug Revenue by Country (US$ Million) & (2027-2032) Table 97. Europe Computer-Aided Drug Revenue by Type (2021-2026) & (US$ Million) Table 98. Europe Computer-Aided Drug Revenue by Type (2027-2032) & (US$ Million) Table 99. Europe Computer-Aided Drug Revenue by Application (2021-2026) & (US$ Million) Table 100. Europe Computer-Aided Drug Revenue by Application (2027-2032) & (US$ Million) Table 101. Europe Computer-Aided Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. Europe Computer-Aided Drug Revenue by Country (2021-2026) & (US$ Million) Table 103. Europe Computer-Aided Drug Revenue by Country (US$ Million) & (2027-2032) Table 104. China Computer-Aided Drug Revenue by Type (2021-2026) & (US$ Million) Table 105. China Computer-Aided Drug Revenue by Type (2027-2032) & (US$ Million) Table 106. China Computer-Aided Drug Revenue by Application (2021-2026) & (US$ Million) Table 107. China Computer-Aided Drug Revenue by Application (2027-2032) & (US$ Million) Table 108. Asia Computer-Aided Drug Revenue by Type (2021-2026) & (US$ Million) Table 109. Asia Computer-Aided Drug Revenue by Type (2027-2032) & (US$ Million) Table 110. Asia Computer-Aided Drug Revenue by Application (2021-2026) & (US$ Million) Table 111. Asia Computer-Aided Drug Revenue by Application (2027-2032) & (US$ Million) Table 112. Asia Computer-Aided Drug Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 113. Asia Computer-Aided Drug Revenue by Region (US$ Million) & (2021-2026) Table 114. Asia Computer-Aided Drug Revenue by Region (US$ Million) & (2027-2032) Table 115. SAMEA Computer-Aided Drug Revenue by Type (2021-2026) & (US$ Million) Table 116. SAMEA Computer-Aided Drug Revenue by Type (2027-2032) & (US$ Million) Table 117. SAMEA Computer-Aided Drug Revenue by Application (2021-2026) & (US$ Million) Table 118. SAMEA Computer-Aided Drug Revenue by Application (2027-2032) & (US$ Million) Table 119. SAMEA Computer-Aided Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. SAMEA Computer-Aided Drug Revenue by Country (2021-2026) & (US$ Million) Table 121. SAMEA Computer-Aided Drug Revenue by Country (US$ Million) & (2027-2032) Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. Computer-Aided Drug Image Figure 2. Global Computer-Aided Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Computer-Aided Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Structure Based Drug Image Figure 5. Ligand Based Drug Image Figure 6. Global Computer-Aided Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Computer-Aided Drug Market Size Share 2021 VS 2025 VS 2032 Figure 8. Oncological Disorders Image Figure 9. Neurological Disorders Image Figure 10. Other Image Figure 11. Global Computer-Aided Drug Market Size (US$ Million) & (2021-2032) Figure 12. Global Computer-Aided Drug Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Computer-Aided Drug Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Computer-Aided Drug Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Computer-Aided Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Computer-Aided Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Computer-Aided Drug Revenue Market Share by Type (2021-2032) Figure 19. Global Computer-Aided Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Computer-Aided Drug Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Computer-Aided Drug Revenue Market Share by Application (2021-2032) Figure 22. North America Computer-Aided Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Computer-Aided Drug Revenue Share by Type (2021-2032) Figure 24. North America Computer-Aided Drug Revenue Share by Application (2021-2032) Figure 25. North America Computer-Aided Drug Revenue Share by Country (2021-2032) Figure 26. United States Computer-Aided Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Computer-Aided Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Computer-Aided Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Computer-Aided Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Computer-Aided Drug Revenue Share by Type (2021-2032) Figure 31. Europe Computer-Aided Drug Revenue Share by Application (2021-2032) Figure 32. Europe Computer-Aided Drug Revenue Share by Country (2021-2032) Figure 33. Germany Computer-Aided Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Computer-Aided Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Computer-Aided Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Computer-Aided Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Computer-Aided Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Computer-Aided Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Computer-Aided Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Computer-Aided Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Computer-Aided Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Computer-Aided Drug Revenue Share by Type (2021-2032) Figure 43. China Computer-Aided Drug Revenue Share by Application (2021-2032) Figure 44. Asia Computer-Aided Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Computer-Aided Drug Revenue Share by Type (2021-2032) Figure 46. Asia Computer-Aided Drug Revenue Share by Application (2021-2032) Figure 47. Asia Computer-Aided Drug Revenue Share by Region (2021-2032) Figure 48. Japan Computer-Aided Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Computer-Aided Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Computer-Aided Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Computer-Aided Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Computer-Aided Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Computer-Aided Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Computer-Aided Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Computer-Aided Drug Revenue Share by Type (2021-2032) Figure 56. SAMEA Computer-Aided Drug Revenue Share by Application (2021-2032) Figure 57. SAMEA Computer-Aided Drug Revenue Share by Country (2021-2032) Figure 58. Brazil Computer-Aided Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Computer-Aided Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Computer-Aided Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Computer-Aided Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Computer-Aided Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Computer-Aided Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Computer-Aided Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Computer-Aided Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Computer-Aided Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Computer-Aided Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Computer-Aided Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Structure Based Drug
  • Ligand Based Drug
Applications
  • Oncological Disorders
  • Neurological Disorders
  • Other
Companies covered
  • Aaranya Biosciences Pvt. Ltd.
  • Albany Molecular Research Inc.
  • Charles River Laboratories International Inc.
  • Chembio Discovery Inc.
  • Chemical Computing Group ULC
  • Compchem Solutions Ltd.
  • International Business Machines Corp.
  • Kang Yusheng Information Technology Co. Ltd.
  • Market Positioning Of Vendors
  • Openeye Scientific Software Inc.
  • Pharmaron Beijing Co. Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Computer-Aided Drug Market by Type
  3. 1.2.1 Global Computer-Aided Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Structure Based Drug
  5. 1.2.3 Ligand Based Drug
  6. 1.3 Computer-Aided Drug Market by Application
  7. 1.3.1 Global Computer-Aided Drug Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Oncological Disorders
  9. 1.3.3 Neurological Disorders
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Computer-Aided Drug Market Dynamics
  1. 2.1 Computer-Aided Drug Industry Trends
  2. 2.2 Computer-Aided Drug Industry Drivers
  3. 2.3 Computer-Aided Drug Industry Opportunities and Challenges
  4. 2.4 Computer-Aided Drug Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Computer-Aided Drug Market Perspective (2021-2032)
  2. 3.2 Global Computer-Aided Drug Growth Trends by Region
  3. 3.2.1 Global Computer-Aided Drug Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Computer-Aided Drug Market Size by Region (2021-2026)
  5. 3.2.3 Global Computer-Aided Drug Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Computer-Aided Drug Revenue by Players
  2. 4.1.1 Global Computer-Aided Drug Revenue by Players (2021-2026)
  3. 4.1.2 Global Computer-Aided Drug Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Computer-Aided Drug Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Computer-Aided Drug Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Computer-Aided Drug Key Players Headquarters & Area Served
  7. 4.4 Global Computer-Aided Drug Players, Product Type & Application
  8. 4.5 Global Computer-Aided Drug Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Computer-Aided Drug Market CR5 and HHI
  11. 4.6.3 2025 Computer-Aided Drug Tier 1, Tier 2, and Tier 3
5 Computer-Aided Drug Market Size by Type
  1. 5.1 Global Computer-Aided Drug Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Computer-Aided Drug Revenue by Type (2021-2032)
  3. 5.3 Global Computer-Aided Drug Revenue Market Share by Type (2021-2032)
6 Computer-Aided Drug Market Size by Application
  1. 6.1 Global Computer-Aided Drug Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Computer-Aided Drug Revenue by Application (2021-2032)
  3. 6.3 Global Computer-Aided Drug Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Aaranya Biosciences Pvt. Ltd.
  2. 7.1.1 Aaranya Biosciences Pvt. Ltd. Company Information
  3. 7.1.2 Aaranya Biosciences Pvt. Ltd. Business Overview
  4. 7.1.3 Aaranya Biosciences Pvt. Ltd. Computer-Aided Drug Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Aaranya Biosciences Pvt. Ltd. Computer-Aided Drug Product Portfolio
  6. 7.1.5 Aaranya Biosciences Pvt. Ltd. Recent Developments
  7. 7.2 Albany Molecular Research Inc.
  8. 7.2.1 Albany Molecular Research Inc. Company Information
  9. 7.2.2 Albany Molecular Research Inc. Business Overview
  10. 7.2.3 Albany Molecular Research Inc. Computer-Aided Drug Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Albany Molecular Research Inc. Computer-Aided Drug Product Portfolio
  12. 7.2.5 Albany Molecular Research Inc. Recent Developments
  13. 7.3 Charles River Laboratories International Inc.
  14. 7.3.1 Charles River Laboratories International Inc. Company Information
  15. 7.3.2 Charles River Laboratories International Inc. Business Overview
  16. 7.3.3 Charles River Laboratories International Inc. Computer-Aided Drug Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Charles River Laboratories International Inc. Computer-Aided Drug Product Portfolio
  18. 7.3.5 Charles River Laboratories International Inc. Recent Developments
  19. 7.4 Chembio Discovery Inc.
  20. 7.4.1 Chembio Discovery Inc. Company Information
  21. 7.4.2 Chembio Discovery Inc. Business Overview
  22. 7.4.3 Chembio Discovery Inc. Computer-Aided Drug Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Chembio Discovery Inc. Computer-Aided Drug Product Portfolio
  24. 7.4.5 Chembio Discovery Inc. Recent Developments
  25. 7.5 Chemical Computing Group ULC
  26. 7.5.1 Chemical Computing Group ULC Company Information
  27. 7.5.2 Chemical Computing Group ULC Business Overview
  28. 7.5.3 Chemical Computing Group ULC Computer-Aided Drug Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Chemical Computing Group ULC Computer-Aided Drug Product Portfolio
  30. 7.5.5 Chemical Computing Group ULC Recent Developments
  31. 7.6 Compchem Solutions Ltd.
  32. 7.6.1 Compchem Solutions Ltd. Company Information
  33. 7.6.2 Compchem Solutions Ltd. Business Overview
  34. 7.6.3 Compchem Solutions Ltd. Computer-Aided Drug Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Compchem Solutions Ltd. Computer-Aided Drug Product Portfolio
  36. 7.6.5 Compchem Solutions Ltd. Recent Developments
  37. 7.7 International Business Machines Corp.
  38. 7.7.1 International Business Machines Corp. Company Information
  39. 7.7.2 International Business Machines Corp. Business Overview
  40. 7.7.3 International Business Machines Corp. Computer-Aided Drug Revenue and Gross Margin (2021-2026)
  41. 7.7.4 International Business Machines Corp. Computer-Aided Drug Product Portfolio
  42. 7.7.5 International Business Machines Corp. Recent Developments
  43. 7.8 Kang Yusheng Information Technology Co. Ltd.
  44. 7.8.1 Kang Yusheng Information Technology Co. Ltd. Company Information
  45. 7.8.2 Kang Yusheng Information Technology Co. Ltd. Business Overview
  46. 7.8.3 Kang Yusheng Information Technology Co. Ltd. Computer-Aided Drug Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Kang Yusheng Information Technology Co. Ltd. Computer-Aided Drug Product Portfolio
  48. 7.8.5 Kang Yusheng Information Technology Co. Ltd. Recent Developments
  49. 7.9 Market Positioning Of Vendors
  50. 7.9.1 Market Positioning Of Vendors Company Information
  51. 7.9.2 Market Positioning Of Vendors Business Overview
  52. 7.9.3 Market Positioning Of Vendors Computer-Aided Drug Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Market Positioning Of Vendors Computer-Aided Drug Product Portfolio
  54. 7.9.5 Market Positioning Of Vendors Recent Developments
  55. 7.10 Openeye Scientific Software Inc.
  56. 7.10.1 Openeye Scientific Software Inc. Company Information
  57. 7.10.2 Openeye Scientific Software Inc. Business Overview
  58. 7.10.3 Openeye Scientific Software Inc. Computer-Aided Drug Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Openeye Scientific Software Inc. Computer-Aided Drug Product Portfolio
  60. 7.10.5 Openeye Scientific Software Inc. Recent Developments
  61. 7.11 Pharmaron Beijing Co. Ltd.
  62. 7.11.1 Pharmaron Beijing Co. Ltd. Company Information
  63. 7.11.2 Pharmaron Beijing Co. Ltd. Business Overview
  64. 7.11.3 Pharmaron Beijing Co. Ltd. Computer-Aided Drug Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Pharmaron Beijing Co. Ltd. Computer-Aided Drug Product Portfolio
  66. 7.11.5 Pharmaron Beijing Co. Ltd. Recent Developments
8 North America
  1. 8.1 North America Computer-Aided Drug Revenue (2021-2032)
  2. 8.2 North America Computer-Aided Drug Revenue by Type (2021-2032)
  3. 8.2.1 North America Computer-Aided Drug Revenue by Type (2021-2026)
  4. 8.2.2 North America Computer-Aided Drug Revenue by Type (2027-2032)
  5. 8.3 North America Computer-Aided Drug Revenue Share by Type (2021-2032)
  6. 8.4 North America Computer-Aided Drug Revenue by Application (2021-2032)
  7. 8.4.1 North America Computer-Aided Drug Revenue by Application (2021-2026)
  8. 8.4.2 North America Computer-Aided Drug Revenue by Application (2027-2032)
  9. 8.5 North America Computer-Aided Drug Revenue Share by Application (2021-2032)
  10. 8.6 North America Computer-Aided Drug Revenue by Country
  11. 8.6.1 North America Computer-Aided Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Computer-Aided Drug Revenue by Country (2021-2026)
  13. 8.6.3 North America Computer-Aided Drug Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Computer-Aided Drug Revenue (2021-2032)
  2. 9.2 Europe Computer-Aided Drug Revenue by Type (2021-2032)
  3. 9.2.1 Europe Computer-Aided Drug Revenue by Type (2021-2026)
  4. 9.2.2 Europe Computer-Aided Drug Revenue by Type (2027-2032)
  5. 9.3 Europe Computer-Aided Drug Revenue Share by Type (2021-2032)
  6. 9.4 Europe Computer-Aided Drug Revenue by Application (2021-2032)
  7. 9.4.1 Europe Computer-Aided Drug Revenue by Application (2021-2026)
  8. 9.4.2 Europe Computer-Aided Drug Revenue by Application (2027-2032)
  9. 9.5 Europe Computer-Aided Drug Revenue Share by Application (2021-2032)
  10. 9.6 Europe Computer-Aided Drug Revenue by Country
  11. 9.6.1 Europe Computer-Aided Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Computer-Aided Drug Revenue by Country (2021-2026)
  13. 9.6.3 Europe Computer-Aided Drug Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Computer-Aided Drug Revenue (2021-2032)
  2. 10.2 China Computer-Aided Drug Revenue by Type (2021-2032)
  3. 10.2.1 China Computer-Aided Drug Revenue by Type (2021-2026)
  4. 10.2.2 China Computer-Aided Drug Revenue by Type (2027-2032)
  5. 10.3 China Computer-Aided Drug Revenue Share by Type (2021-2032)
  6. 10.4 China Computer-Aided Drug Revenue by Application (2021-2032)
  7. 10.4.1 China Computer-Aided Drug Revenue by Application (2021-2026)
  8. 10.4.2 China Computer-Aided Drug Revenue by Application (2027-2032)
  9. 10.5 China Computer-Aided Drug Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Computer-Aided Drug Revenue (2021-2032)
  2. 11.2 Asia Computer-Aided Drug Revenue by Type (2021-2032)
  3. 11.2.1 Asia Computer-Aided Drug Revenue by Type (2021-2026)
  4. 11.2.2 Asia Computer-Aided Drug Revenue by Type (2027-2032)
  5. 11.3 Asia Computer-Aided Drug Revenue Share by Type (2021-2032)
  6. 11.4 Asia Computer-Aided Drug Revenue by Application (2021-2032)
  7. 11.4.1 Asia Computer-Aided Drug Revenue by Application (2021-2026)
  8. 11.4.2 Asia Computer-Aided Drug Revenue by Application (2027-2032)
  9. 11.5 Asia Computer-Aided Drug Revenue Share by Application (2021-2032)
  10. 11.6 Asia Computer-Aided Drug Revenue by Country
  11. 11.6.1 Asia Computer-Aided Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Computer-Aided Drug Revenue by Country (2021-2026)
  13. 11.6.3 Asia Computer-Aided Drug Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Computer-Aided Drug Revenue (2021-2032)
  2. 12.2 SAMEA Computer-Aided Drug Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Computer-Aided Drug Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Computer-Aided Drug Revenue by Type (2027-2032)
  5. 12.3 SAMEA Computer-Aided Drug Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Computer-Aided Drug Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Computer-Aided Drug Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Computer-Aided Drug Revenue by Application (2027-2032)
  9. 12.5 SAMEA Computer-Aided Drug Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Computer-Aided Drug Revenue by Country
  11. 12.6.1 SAMEA Computer-Aided Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Computer-Aided Drug Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Computer-Aided Drug Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst